Bivalirudin nonclinical toxicology: Difference between revisions

Jump to navigation Jump to search
Newer edit →
VisualWikitext
Jesus Hernandez (talk | contribs)
nocaptcha
4,185 edits
Created page with "__NOTOC__ {{Bivalirudin}} {{CMG}} {{AE}}{{JH}} ==Title== <ref>{{Cite web | last = | first = | title = ANGIOMAX (BIVALIRUDIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTIO..."
 
Alejandro Lemor (talk | contribs)
nocaptcha, Administrators
7,091 edits
Line 1: Line 1:
__NOTOC__
#REDIRECT [[Bivalirudin#Nonclinical Toxicology]]
{{Bivalirudin}}
{{CMG}} {{AE}}{{JH}}


==Title==
[[Category: Cardiovascular Drugs]]
 
[[Category: Drug]]
 
[[Category: Anticoagulants]]
 
<ref>{{Cite web  | last =  | first =  | title = ANGIOMAX (BIVALIRUDIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [THE MEDICINES COMPANY] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=911cd48f-01ea-4dec-b30c-95e7e0ea9d2a | publisher =  | date =  | accessdate = 10 March 2014 }}</ref>
 
==References==
 
{{Reflist}}
 
{{FDA}}
 
[[Category:Cardiovascular Drugs]]
[[Category:Drugs]]

Revision as of 18:55, 21 July 2014

Redirect to:

Retrieved from "https://www.wikidoc.org/index.php?title=Bivalirudin_nonclinical_toxicology&oldid=997071"